VYCO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 Apr 2024 @ 15:52):

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision...

Stats
Today's Volume	728.00
Average Volume	4 148.00
Market Cap	2.74M
EPS	$0 ( 2024-04-16 )
Next earnings date	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.40
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-09-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2022-06-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2022-03-31	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2021-09-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock
2021-09-30	Fountainhead Capital Management Ltd	Buy	535 714	Common stock

INSIDER POWER
100.00
Last 99 transactions
Buy: 21 534 905 \| Sell: 2 437 499

Vycor Medical, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vycor Medical, Inc. Financials

Annual	2022
Revenue:	$1.22M
Gross Profit:	$1.08M (88.50 %)
EPS:	$-0.0128

Q3	2023
Revenue:	$308 593
Gross Profit:	$276 259 (89.52 %)
EPS:	$-0.00160

Q2	2023
Revenue:	$482 768
Gross Profit:	$442 971 (91.76 %)
EPS:	$0.00210

Q1	2023
Revenue:	$360 994
Gross Profit:	$330 195 (91.47 %)
EPS:	$-0.000900

Financial Reports:

No articles found.

Vycor Medical, Inc.

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.